This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (10)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Allegations of ethical problems in psychiatric research have received intense public attention in the past few years. Two of the most widely publicized examples are research involving withdrawing medication from patients with schizophrenia at the University of California, Los Angeles, investigated by the US Office of Protection From Research Risks, and litigation concerning research conducted by the New York State Office of Mental Health.^1-2 Philip J. Hilts, writing in the science section of The New York Times, described a range of psychiatric research considered to be ethically problematic, including "challenge" experiments in which psychiatric patients were administered drugs to study provoked symptoms.³ The Boston Globe recently published a 4-part series, entitled "Doing Harm: Research on the Mentally Ill," detailing alleged abuses of human subjects in psychiatric research.^4-7 The use of placebos in research that tests new drugs to treat psychiatric disorders has also been criticized in the professional medical . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Continued Controversies: Issues in Mental Health Research and Implications for Nursing
Spath
J Am Psychiatr Nurses Assoc 2007;13:221-229.
ABSTRACT  

National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Charney et al.
Arch Gen Psychiatry 2002;59:262-270.
ABSTRACT | FULL TEXT